{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:36:33Z","timestamp":1740108993413,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-023-04469-x","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T03:31:27Z","timestamp":1686972687000},"page":"2173-2178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4864-8706","authenticated-orcid":false,"given":"Matthias","family":"Vanneste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"van der Heij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Elisabeth","family":"Christiaansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris L.","family":"Berendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth Johanna Margaretha","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harman Maxim","family":"Bruins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,17]]},"reference":[{"unstructured":"IARC, Cancer Today. Estimated number of new cases in 2020, worldwide, both sexes, all ages. 2021 [access date March 2022]. Accessible through: https:\/\/gco.iarc.fr\/today\/online-analysis-table","key":"4469_CR1"},{"key":"4469_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00428-015-1739-2","volume":"466","author":"E Comp\u00e9rat","year":"2015","unstructured":"Comp\u00e9rat E, Larre S, Roupret M et al (2015) Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch 466:589\u2013594. https:\/\/doi.org\/10.1007\/s00428-015-1739-2","journal-title":"Virchows Arch"},{"issue":"6","key":"4469_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","volume":"73","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Foerster B, Catto JWF et al (2018) Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol 73(6):925\u2013933. https:\/\/doi.org\/10.1016\/j.eururo.2018.02.014","journal-title":"Eur Urol"},{"issue":"4","key":"4469_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.euf.2016.12.011","volume":"4","author":"A Naselli","year":"2018","unstructured":"Naselli A, Hurle R, Paparella S (2018) Role of restaging transurethral resection for T1 non-muscle invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Focus 4(4):558\u2013567. https:\/\/doi.org\/10.1016\/j.euf.2016.12.011","journal-title":"Eur Urol Focus"},{"issue":"1","key":"4469_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Comp\u00e9rat E et al (2022) European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1 and Carcinoma in Situ). Eur Urol 81(1):75\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2021.08.010","journal-title":"Eur Urol"},{"issue":"1","key":"4469_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.eururo.2020.04.056","volume":"78","author":"MJ Ribal","year":"2020","unstructured":"Ribal MJ, Cornford P, Briganti A et al (2020) European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the EAU guidelines recommendations to the COVID-19 era. Eur Urol 78(1):21\u201328. https:\/\/doi.org\/10.1016\/j.eururo.2020.04.056","journal-title":"Eur Urol"},{"issue":"1","key":"4469_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/bju.13354","volume":"118","author":"P Gontero","year":"2016","unstructured":"Gontero P, Sylvester R, Pisano F et al (2016) The impact of re-transurethral resection on clinical outcomes in a large multicenter cohort of patients with T1 high-grade\/Grade 3 bladder cancer treated with bacille Calmette-Guerin. BJU Int 118(1):44\u201352. https:\/\/doi.org\/10.1111\/bju.13354","journal-title":"BJU Int"},{"key":"4469_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3389\/fonc.2019.00465","volume":"9","author":"B Cal\u00f2","year":"2019","unstructured":"Cal\u00f2 B, Chirico M, Fortunato F et al (2019) Is repeat transurethral resection always needed in high-grade T1 bladder cancer? Front Oncol 9:465. https:\/\/doi.org\/10.3389\/fonc.2019.00465","journal-title":"Front Oncol"},{"doi-asserted-by":"publisher","unstructured":"van Ek G, Biddingh T, van Gennep E et al (2019) The value of repeat transurethral resection in non-invasive (Ta) high-grade bladder cancer; a\u00a0retrospective multicenter analysis. Tijdschrift voor Urologie\u00a09:68\u201373. https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s13629-018-0243-2","key":"4469_CR9","DOI":"10.1007\/s13629-018-0243-2"},{"unstructured":"Moch H, Humphrey PA, Ulbright TM et al (2016) WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th Edn, vol 8. IARC Publications, WHO","key":"4469_CR10"},{"key":"4469_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-x","volume":"17","author":"M Schemper","year":"1996","unstructured":"Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17:343\u2013346. https:\/\/doi.org\/10.1016\/0197-2456(96)00075-x","journal-title":"Control Clin Trials"},{"issue":"2","key":"4469_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00005392-200102000-00011","volume":"165","author":"D Mack","year":"2001","unstructured":"Mack D, H\u00f6ltl W, Bassi P et al (2001) The ablative effect of quarter dose bacillus Calmette-Guerin on a papillary marker lesion of the bladder. J Urol 165(2):401\u2013403. https:\/\/doi.org\/10.1097\/00005392-200102000-00011","journal-title":"J Urol"},{"issue":"4","key":"4469_CR13","doi-asserted-by":"publisher","first-page":"166.e1","DOI":"10.1016\/j.urolonc.2015.11.006","volume":"34","author":"HM Bruins","year":"2016","unstructured":"Bruins HM, Aben KKH, Arends TJ et al (2016) The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis. Urol Oncol 34(4):166.e1\u20136. https:\/\/doi.org\/10.1016\/j.urolonc.2015.11.006","journal-title":"Urol Oncol"},{"issue":"6","key":"4469_CR14","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1097\/JU.0000000000001633","volume":"205","author":"TM Justin","year":"2021","unstructured":"Justin TM, Li R, Hensley PJ et al (2021) Contemporary outcomes of patients with nonmuscle-invasive bladder cancer Treated with bacillus Calmette-Guerin: implications for clinical trial design. J Urol 205(6):1612\u20131621. https:\/\/doi.org\/10.1097\/JU.0000000000001633","journal-title":"J Urol"},{"issue":"10","key":"4469_CR15","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1007\/s00345-021-03690-w","volume":"39","author":"B Cal\u00f2","year":"2021","unstructured":"Cal\u00f2 B, Sanguedolce F, Falagario U et al (2021) Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? World J Urol 39(10):3815\u20133821. https:\/\/doi.org\/10.1007\/s00345-021-03690-w","journal-title":"World J Urol"},{"issue":"5","key":"4469_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00345-016-1927-y","volume":"35","author":"AI Rolevich","year":"2017","unstructured":"Rolevich AI, Zhegalik AG, Mokhort AA et al (2017) Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer. World J Urol 35(5):745\u2013752. https:\/\/doi.org\/10.1007\/s00345-016-1927-y","journal-title":"World J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04469-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-023-04469-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04469-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T11:27:21Z","timestamp":1691666841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-023-04469-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,17]]},"references-count":16,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["4469"],"URL":"https:\/\/doi.org\/10.1007\/s00345-023-04469-x","relation":{},"ISSN":["1433-8726"],"issn-type":[{"type":"electronic","value":"1433-8726"}],"subject":[],"published":{"date-parts":[[2023,6,17]]},"assertion":[{"value":"23 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was reviewed and approved by the hospital\u2019s medical ethical committee METCZ (\u2018<i>\u2019Medisch Ethische ToetsingsCommissie van Zuyderland\u2019\u2019<\/i>) under registration number METCZ20220074. All procedures used in this study adhere to the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The need for individual patient\u2019s informed consent was waived by the hospital\u2019s medical ethical committee in view of the retrospective nature of the study, the processing of only anonymous data and all procedures being part of the routine care.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}